Joël Gsponer

930 total citations
17 papers, 675 citations indexed

About

Joël Gsponer is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Joël Gsponer has authored 17 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Joël Gsponer's work include Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Treatment and Research (6 papers) and Immune responses and vaccinations (3 papers). Joël Gsponer is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Treatment and Research (6 papers) and Immune responses and vaccinations (3 papers). Joël Gsponer collaborates with scholars based in Switzerland, France and United States. Joël Gsponer's co-authors include Cyrill A. Rentsch, Alexander Bachmann, George N. Thalmann, Claire Biot, Matthew L. Albert, Frédéric D. Birkhäuser, Christian Ruiz, Lukas Bubendorf, Fabrice Lemaı̂tre and Lucie Peduto and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Joël Gsponer

17 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joël Gsponer Switzerland 11 273 242 213 185 160 17 675
Shugo Tamada Japan 9 339 1.2× 321 1.3× 330 1.5× 68 0.4× 118 0.7× 14 660
Matthew D. Stachler United States 15 340 1.2× 320 1.3× 344 1.6× 117 0.6× 98 0.6× 38 911
George Vlahos Greece 12 124 0.5× 274 1.1× 182 0.9× 202 1.1× 79 0.5× 22 663
William R. Fair United States 9 331 1.2× 214 0.9× 238 1.1× 65 0.4× 119 0.7× 14 712
Kyriakos Chatzopoulos Greece 11 92 0.3× 298 1.2× 135 0.6× 143 0.8× 68 0.4× 40 491
G. B. Snow Netherlands 12 195 0.7× 338 1.4× 286 1.3× 82 0.4× 129 0.8× 17 788
Tine S. Mantoni United Kingdom 7 89 0.3× 377 1.6× 178 0.8× 73 0.4× 116 0.7× 9 524
Chang Gon Kim South Korea 11 90 0.3× 470 1.9× 282 1.3× 364 2.0× 99 0.6× 15 893
C. Weber United States 4 85 0.3× 428 1.8× 389 1.8× 298 1.6× 121 0.8× 7 796
Marie‐Aude Lefrère‐Belda France 10 423 1.5× 139 0.6× 387 1.8× 68 0.4× 72 0.5× 12 817

Countries citing papers authored by Joël Gsponer

Since Specialization
Citations

This map shows the geographic impact of Joël Gsponer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joël Gsponer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joël Gsponer more than expected).

Fields of papers citing papers by Joël Gsponer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joël Gsponer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joël Gsponer. The network helps show where Joël Gsponer may publish in the future.

Co-authorship network of co-authors of Joël Gsponer

This figure shows the co-authorship network connecting the top 25 collaborators of Joël Gsponer. A scholar is included among the top collaborators of Joël Gsponer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joël Gsponer. Joël Gsponer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Juškevičius, Darius, Joël Gsponer, Valeria Perrina, et al.. (2016). Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia. 30(12). 2385–2395. 63 indexed citations
2.
Wetterauer, Christian, Tatjana Vlajnic, Julia Schüler, et al.. (2015). 410 Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice. European Urology Supplements. 14(2). e410–e410. 1 indexed citations
3.
Wetterauer, Christian, Tatjana Vlajnic, Julia Schüler, et al.. (2015). Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out Immunocompromised mice. The Prostate. 75(6). 585–592. 41 indexed citations
4.
Rentsch, Cyrill A., Frédéric D. Birkhäuser, Claire Biot, et al.. (2014). Bacillus Calmette-Guérin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy. European Urology. 66(4). 677–688. 130 indexed citations
5.
Wetterauer, Christian, Joël Gsponer, Tatjana Vlajnic, et al.. (2014). Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(6). 629–636. 9 indexed citations
6.
Müller, Georg, Malte Rieken, Gernot Bonkat, et al.. (2014). Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(4). 429–437. 4 indexed citations
7.
Gsponer, Joël, Martin Braun, Veit Scheble, et al.. (2014). ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17(2). 126–131. 17 indexed citations
8.
Rentsch, Cyrill A., Christian Wetterauer, Joël Gsponer, et al.. (2014). 521 VPM1002 – a recombinant BCG with favourable preclinical toxicity and immunogenicity for potential improvement of BCG immunotherapy for non-muscle invasive bladder cancer. European Urology Supplements. 13(1). e521–e521. 2 indexed citations
9.
Arabi, Leila, Joël Gsponer, Jan Smida, et al.. (2014). Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences. Genes & Cancer. 5(1-2). 56–63. 31 indexed citations
10.
Magnen, Clémentine Le, Lukas Bubendorf, Cyrill A. Rentsch, et al.. (2013). Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer. Clinical Cancer Research. 19(19). 5361–5371. 67 indexed citations
11.
Andreozzi, Mariacarla, Luca Quagliata, Joël Gsponer, et al.. (2013). VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities. Angiogenesis. 17(3). 519–527. 18 indexed citations
12.
Rentsch, Cyrill A., Claire Biot, Joël Gsponer, et al.. (2013). BCG-Mediated Bladder Cancer Immunotherapy: Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model. PLoS ONE. 8(2). e56327–e56327. 11 indexed citations
13.
Zellweger, Tobias, Inti Zlobec, Joël Gsponer, et al.. (2013). Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naïve prostate cancer and are elevated in castration-resistant disease. Endocrine Related Cancer. 20(3). 403–413. 36 indexed citations
14.
Bubendorf, Lukas, Cyrill A. Rentsch, Chantal Mengus, et al.. (2013). Characterization and Clinical Relevance of ALDH bright Populations in Prostate Cancer. 6 indexed citations
15.
Holley, Tara, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples. PLoS ONE. 7(11). e50586–e50586. 38 indexed citations
16.
Biot, Claire, Cyrill A. Rentsch, Joël Gsponer, et al.. (2012). Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer. Science Translational Medicine. 4(137). 137ra72–137ra72. 195 indexed citations
17.
Gsponer, Joël, Claire Biot, Aurélie Bisiaux, et al.. (2012). Abstract 5386: Immunotherapy of bladder cancer using bacillus calmette guerin (BCG): Generation of cytotoxic T-cells is BCG strain dependent. Cancer Research. 72(8_Supplement). 5386–5386. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026